How many drugs treat Constipation?

Drug Landscape tracks 10 marketed treatments for Constipation (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/constipation.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Constipation — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Constipation (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Constipation, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cholbam	CHOLIC ACID	Mirum	Bile Acid [EPC]	G-protein coupled bile acid receptor 1	2015-01-01
Halflytely	BISACODYL	Braintree	Stimulant Laxative [EPC]	Kappa-type opioid receptor	2004-01-01
Renacidin	MAGNESIUM CARBONATE	United Guardian	Vitamin C [EPC]		1990-01-01
Miralax	Macrogol	Braintree	Osmotic Laxative [EPC]		1984-01-01
Prepopik	MAGNESIUM OXIDE	Baxter	magnesium oxide		1982-01-01
Cephulac	LACTULOSE	Sanwa Kagaku Kenkyusho Co., Ltd.	Osmotic Laxative [EPC]		1976-01-01
Micro-K 10	POTASSIUM CHLORIDE	Nesher Pharms	potassium chloride	Carbonic anhydrase 4	1965-01-01
Colace	docusate sodium	Generic (multiple manufacturers)	Stool softener (surfactant laxative)	N/A (surfactant mechanism)	1955-01-01
Milk of Magnesia	magnesium hydroxide	Generic (multiple manufacturers)	Osmotic laxative, Antacid	Gastric acid (direct neutralization) + osmotic effect in intestine	1880-01-01
Senna-S	SENNA	HealthLife of USA LLC

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 8 drugs in Constipation
Generic (multiple manufacturers) · 2 drugs in Constipation
Braintree · 2 drugs in Constipation
HealthLife of USA LLC · 1 drug in Constipation
Mirum · 1 drug in Constipation
Mirum Pharmaceuticals, Inc. · 1 drug in Constipation
Napp Pharmaceuticals Ltd · 1 drug in Constipation
Nesher Pharms · 1 drug in Constipation
OTSUKA ICU MEDCL · 1 drug in Constipation
Rutgers, The State University of New Jersey · 1 drug in Constipation
Sanwa Kagaku Kenkyusho Co., Ltd. · 1 drug in Constipation
The Wellness Center · 1 drug in Constipation

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Constipation:

Cite this brief

Drug Landscape (2026). Constipation — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/constipation. Accessed 2026-06-10.

Constipation full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing